CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.9967
0.31%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0031
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Bruker Cellular Analysis Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.9936
Open* 0.9957
1-Year Change* -67.03%
Day's Range* 0.9956 - 0.9971
52 wk Range 0.38-4.12
Average Volume (10 days) 1.95M
Average Volume (3 months) 34.38M
Market Cap 97.32M
P/E Ratio -100.00K
Shares Outstanding 98.98M
Revenue 71.82M
EPS -1.54
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Nov 6, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 0.9967 0.0010 0.10% 0.9957 0.9971 0.9956
Sep 28, 2023 0.9936 0.0010 0.10% 0.9926 0.9971 0.9915
Sep 27, 2023 0.9916 0.0015 0.15% 0.9901 0.9919 0.9901
Sep 26, 2023 0.9915 0.0008 0.08% 0.9907 0.9919 0.9901
Sep 25, 2023 0.9909 0.0021 0.21% 0.9888 0.9953 0.9888
Sep 22, 2023 0.9890 0.0003 0.03% 0.9887 0.9892 0.9866
Sep 21, 2023 0.9886 -0.0001 -0.01% 0.9887 0.9943 0.9861
Sep 20, 2023 0.9887 0.0000 0.00% 0.9887 0.9902 0.9885
Sep 19, 2023 0.9887 0.0041 0.42% 0.9846 0.9899 0.9845
Sep 18, 2023 0.9847 0.0011 0.11% 0.9836 0.9946 0.9836
Sep 15, 2023 0.9857 0.0021 0.21% 0.9836 0.9913 0.9819
Sep 14, 2023 0.9817 0.0000 0.00% 0.9817 0.9838 0.9816
Sep 13, 2023 0.9818 0.0002 0.02% 0.9816 0.9873 0.9807
Sep 12, 2023 0.9820 -0.0016 -0.16% 0.9836 0.9836 0.9797
Sep 11, 2023 0.9804 -0.0012 -0.12% 0.9816 0.9840 0.9796
Sep 8, 2023 0.9811 -0.0007 -0.07% 0.9818 0.9838 0.9806
Sep 7, 2023 0.9818 0.0007 0.07% 0.9811 0.9839 0.9807
Sep 6, 2023 0.9827 0.0041 0.42% 0.9786 0.9851 0.9786
Sep 5, 2023 0.9806 0.0128 1.32% 0.9678 0.9883 0.9593
Sep 1, 2023 0.9687 0.0100 1.04% 0.9587 0.9741 0.9587

PhenomeX Inc. Events

Time (UTC) Country Event
Wednesday, February 21, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 PhenomeX Inc Earnings Release
Q4 2023 PhenomeX Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 78.595 85.388 64.303 56.693 31.299
Revenue 78.595 85.388 64.303 56.693 31.299
Cost of Revenue, Total 24.814 28.837 19.748 13.217 8.181
Gross Profit 53.781 56.551 44.555 43.476 23.118
Total Operating Expense 176.649 156.177 104.697 73.23 52.458
Selling/General/Admin. Expenses, Total 95.115 68.787 37.709 21.599 15.2
Research & Development 53.207 58.553 47.24 38.414 29.077
Operating Income -98.054 -70.789 -40.394 -16.537 -21.159
Interest Income (Expense), Net Non-Operating 0.114 -0.99 -1.098 -0.516 -1.332
Other, Net 0.082 -1.18 -0.777
Net Income Before Taxes -97.94 -71.779 -41.41 -18.233 -23.268
Net Income After Taxes -98.04 -71.724 -41.584 -18.302 -23.337
Net Income Before Extra. Items -98.04 -71.724 -41.584 -18.302 -23.337
Net Income -98.04 -71.724 -41.584 -18.302 -23.337
Total Adjustments to Net Income 0 -1.735 -3.198 -3.198
Income Available to Common Excl. Extra. Items -98.04 -71.724 -43.319 -21.5 -26.535
Income Available to Common Incl. Extra. Items -98.04 -71.724 -43.319 -21.5 -26.535
Diluted Net Income -98.04 -71.724 -43.319 -21.5 -26.535
Diluted Weighted Average Shares 68.8686 66.7071 64.4863 61.6439 61.6439
Diluted EPS Excluding Extraordinary Items -1.42358 -1.07521 -0.67176 -0.34878 -0.43046
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -1.39042 -1.07423 -0.65664 -0.34034 -0.42307
Unusual Expense (Income) 3.513
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 14.062 18.516 17.841 21.398 19.15
Revenue 14.062 18.516 17.841 21.398 19.15
Cost of Revenue, Total 8.019 5.088 5.838 6.373 6.224
Gross Profit 6.043 13.428 12.003 15.025 12.926
Total Operating Expense 59.469 41.146 47.539 42.934 44.697
Selling/General/Admin. Expenses, Total 26.258 26.547 30.768 26.525 20.295
Research & Development 9.342 8.421 8.478 8.978 18.178
Operating Income -45.407 -22.63 -29.698 -21.536 -25.547
Interest Income (Expense), Net Non-Operating -0.938 0.443 0.451 -0.008 -0.196
Net Income Before Taxes -50.194 -23.399 -29.247 -21.544 -25.743
Net Income After Taxes -50.245 -23.419 -29.301 -21.566 -25.747
Net Income Before Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
Net Income -50.245 -23.419 -29.301 -21.566 -25.747
Income Available to Common Excl. Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
Income Available to Common Incl. Extra. Items -50.245 -23.419 -29.301 -21.566 -25.747
Diluted Net Income -50.245 -23.419 -29.301 -21.566 -25.747
Diluted Weighted Average Shares 98.9008 75.7598 71.3996 68.3841 67.9857
Diluted EPS Excluding Extraordinary Items -0.50803 -0.30912 -0.41038 -0.31537 -0.37871
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.40386 -0.29977 -0.38803 -0.30531 -0.37871
Unusual Expense (Income) 15.85 1.09 2.455 1.058
Other, Net -3.849 -1.212
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 176.952 230.57 265.569 105.347 118.995
Cash and Short Term Investments 132.774 178.096 233.408 81.033 99.617
Cash & Equivalents 86.522 178.096 233.408 81.033 99.617
Total Receivables, Net 19.817 27.678 14.249 14.568 12.369
Accounts Receivable - Trade, Net 19.817 27.678 14.249 14.568 12.369
Total Inventory 18.861 14.547 11.047 7.181 2.866
Other Current Assets, Total 3.475 7.305 4.464 2.565 4.143
Total Assets 226.094 287.253 299.658 131.009 133.819
Property/Plant/Equipment, Total - Net 47.173 54.052 31.262 24.257 14.104
Property/Plant/Equipment, Total - Gross 76.397 75.85 47.6 36.424 24.065
Accumulated Depreciation, Total -29.224 -21.798 -16.338 -12.167 -9.961
Other Long Term Assets, Total 1.42 1.561 2.827 1.405 0.72
Total Current Liabilities 45.49 32.751 28.968 24.919 15.348
Accounts Payable 10.092 8.198 3.491 3.239 2.702
Accrued Expenses 19.721 11.287 7.938 5.266 2.509
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.966 0 11.594 5.765 0
Other Current Liabilities, Total 10.711 13.266 5.945 10.649 10.137
Total Liabilities 84.039 79.037 54.877 47.226 36.188
Total Long Term Debt 14.86 19.762 8.301 14.062 19.763
Long Term Debt 14.86 19.762 8.301 14.062 19.763
Other Liabilities, Total 23.689 26.524 17.608 8.245 1.077
Total Equity 142.055 208.216 244.781 83.783 97.631
Preferred Stock - Non Redeemable, Net 0 0 224.769 224.769
Additional Paid-In Capital 503.708 471.82 436.662 9.314 4.86
Retained Earnings (Accumulated Deficit) -361.648 -263.608 -191.884 -150.3 -131.998
Total Liabilities & Shareholders’ Equity 226.094 287.253 299.658 131.009 133.819
Total Common Shares Outstanding 72.1691 67.5955 64.4863 61.6439 61.6439
Prepaid Expenses 2.025 2.944 2.401
Common Stock 0.004 0.004 0.003
Note Receivable - Long Term 0.549 1.07
Short Term Investments 46.252
Other Equity, Total -0.009
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 131.642 176.952 180.961 192.47 208.364
Cash and Short Term Investments 51.606 132.774 134.715 152.385 164.674
Cash & Equivalents 51.606 86.522 120.64 143.024 164.674
Total Receivables, Net 25.486 19.817 21.557 17.58 19.617
Accounts Receivable - Trade, Net 25.486 19.817 21.557 17.58 19.617
Total Inventory 45.539 18.861 15.706 15.664 15.665
Prepaid Expenses 3.534 2.025 2.414 0.399 1.64
Other Current Assets, Total 5.477 3.475 6.569 6.442 6.768
Total Assets 300.561 226.094 234.884 248.706 265.857
Property/Plant/Equipment, Total - Net 61.291 47.173 51.822 53.839 55.238
Property/Plant/Equipment, Total - Gross 99.542 76.397 79.405 79.605 78.681
Accumulated Depreciation, Total -38.251 -29.224 -27.583 -25.766 -23.443
Note Receivable - Long Term 0.514 0.549 0.681 0.996 0.571
Other Long Term Assets, Total 71.796 1.42 1.42 1.401 1.684
Total Current Liabilities 47.442 45.49 34.38 29.138 27.711
Accounts Payable 17.051 10.092 7.921 8.499 8.015
Accrued Expenses 17.856 19.721 14.819 11.285 9.275
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 4.966 2.483 0
Other Current Liabilities, Total 12.535 10.711 9.157 9.354 10.421
Total Liabilities 142.821 84.039 76.701 74.29 72.656
Total Long Term Debt 68.886 14.86 17.327 19.794 19.778
Long Term Debt 68.886 14.86 17.327 19.794 19.778
Other Liabilities, Total 26.493 23.689 24.994 25.358 25.167
Total Equity 157.74 142.055 158.183 174.416 193.201
Preferred Stock - Non Redeemable, Net
Common Stock 0.005 0.004 0.004 0.004 0.004
Additional Paid-In Capital 542.805 503.708 490.544 485.212 478.231
Retained Earnings (Accumulated Deficit) -385.067 -361.648 -332.347 -310.781 -285.034
Total Liabilities & Shareholders’ Equity 300.561 226.094 234.884 248.706 265.857
Total Common Shares Outstanding 98.7449 72.1691 68.575 68.2739 67.8201
Short Term Investments 0 46.252 14.075 9.361
Other Equity, Total -0.003 -0.009 -0.018 -0.019
Goodwill, Net 12.246
Intangibles, Net 23.072
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -98.04 -71.724 -41.584 -18.302 -23.337
Cash From Operating Activities -47.539 -53.128 -35.852 -10.533 -13.535
Cash From Operating Activities 9.004 5.598 5.102 4.842 4.197
Non-Cash Items 28.042 24.354 12.848 7.492 3.913
Cash Taxes Paid 0.037 0.003 0.108 0.109 0.001
Cash Interest Paid 0.563 0.969 1.368 1.361 1.761
Changes in Working Capital 13.455 -11.356 -12.218 -4.565 1.692
Cash From Investing Activities -53.982 -15.825 -3.289 -9.073 -8.418
Capital Expenditures -8.076 -15.825 -3.289 -8.423 -7.418
Other Investing Cash Flow Items, Total -45.906 0 0 -0.65 -1
Cash From Financing Activities 9.677 13.641 191.516 1.022 95.557
Financing Cash Flow Items 0 -0.3 -2.65 0 -0.273
Issuance (Retirement) of Stock, Net 9.677 13.941 194.166 1.022 94.962
Issuance (Retirement) of Debt, Net 0 0 0 0.868
Net Change in Cash -91.844 -55.312 152.375 -18.584 73.604
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -23.419 -98.04 -68.739 -47.173 -21.426
Cash From Operating Activities -19.553 -47.539 -37.503 -20.588 -10.069
Cash From Operating Activities 2.1 9.004 6.58 4.431 1.944
Non-Cash Items 7.217 28.042 20.302 14.305 6.367
Cash Interest Paid 0.439 0.563 0.422 0.278 0.137
Changes in Working Capital -5.451 13.455 4.354 7.849 3.046
Cash From Investing Activities 5.735 -53.982 -21.775 -16.13 -4.375
Capital Expenditures -0.414 -8.076 -7.732 -6.758 -4.375
Cash From Financing Activities 48.995 9.677 1.552 1.376 1.022
Issuance (Retirement) of Stock, Net 0.195 9.677 1.552 1.376 1.022
Net Change in Cash 35.177 -91.844 -57.726 -35.342 -13.422
Cash Taxes Paid 0.019 0.037 0.01 0
Financing Cash Flow Items -1.2 0 0 0
Other Investing Cash Flow Items, Total 6.149 -45.906 -14.043 -9.372
Issuance (Retirement) of Debt, Net 50 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Berkeley Lights, Inc. Company profile

About Berkeley Lights Inc

Berkeley Lights, Inc. is a digital cell biology company. The Company is focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Company's Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for tens of thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Berkeley Lights platform is a fully integrated, end-to-end solution, consisting of consumables, including its OptoSelect chips and reagent kits, advanced automation systems, and advanced application and workflow software. The Company's platform leverages its OptoElectro Positioning (OEP) technology, which provides deterministic positioning of living single cells and other micro-objects using light. The Company's software products include Cell Analysis Suite (CAS), Workflow Runner/Builder, Assay Analyzer, Image Analyzer, and PrimeSeq.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Berkeley Lights Inc revenues increased 33% to $85.4M. Net loss applicable to common stockholders increased 66% to $71.7M. Revenues reflect Antibody Therapeutics segment increase of 24% to $64.3M, Synthetic Biology segment increase of 11% to $9M, Asia Pacific segment increase of 82% to $35.2M, North America segment increase of 27% to $41.2M.

Industry: Biotechnology & Medical Research (NEC)

5858 Horton Street
Suite 320
EMERYVILLE
CALIFORNIA 94608
US

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

US100

16,001.20 Price
+0.470% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

38,882.05 Price
+0.080% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

XRP/USD

0.62 Price
+0.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Oil - Crude

74.50 Price
-1.560% 1D Chg, %
Long position overnight fee -0.0136%
Short position overnight fee -0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.040

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading